103 related articles for article (PubMed ID: 38716605)
21. [The significance and current diagnostic options of cytogenetic changes in multiple myeloma].
Kuglík P; Filková H; Oltová A; Hájek R
Vnitr Lek; 2006 Nov; 52 Suppl 2():76-8. PubMed ID: 18175433
[TBL] [Abstract][Full Text] [Related]
22. Multicolor spectral karyotyping in multiple myeloma.
Sawyer JR
Methods Mol Med; 2005; 113():49-58. PubMed ID: 15968094
[TBL] [Abstract][Full Text] [Related]
23. Optical genome mapping, a promising alternative to gold standard cytogenetic approaches in a series of acute lymphoblastic leukemias.
Lestringant V; Duployez N; Penther D; Luquet I; Derrieux C; Lutun A; Preudhomme C; West M; Ouled-Haddou H; Devoldere C; Marolleau JP; Garçon L; Jedraszak G; Ferret Y
Genes Chromosomes Cancer; 2021 Oct; 60(10):657-667. PubMed ID: 33982372
[TBL] [Abstract][Full Text] [Related]
24. Optical Genome Mapping Reveals the Complex Genetic Landscape of Myeloma.
Giguère A; Raymond-Bouchard I; Collin V; Claveau JS; Hébert J; LeBlanc R
Cancers (Basel); 2023 Sep; 15(19):. PubMed ID: 37835381
[TBL] [Abstract][Full Text] [Related]
25. A comprehensive approach to evaluate genetic abnormalities in multiple myeloma using optical genome mapping.
Zou YS; Klausner M; Ghabrial J; Stinnett V; Long P; Morsberger L; Murry JB; Beierl K; Gocke CD; Xian RR; Toomer KH; Ye JC; Orlowski RZ; Huff CA; Ali SA; Imus PH; Gocke CB; Tang G
Blood Cancer J; 2024 May; 14(1):78. PubMed ID: 38702349
[No Abstract] [Full Text] [Related]
26. Optical Genome Mapping as an Alternative to FISH-Based Cytogenetic Assessment in Chronic Lymphocytic Leukemia.
Valkama A; Vorimo S; Kumpula TA; Räsänen H; Savolainen ER; Pylkäs K; Mantere T
Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831635
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic classification in Korean multiple myeloma patients: prognostic significance of hyperdiploidy with 47-50 chromosomes and the number of structural abnormalities.
Lim JH; Seo EJ; Park CJ; Jang S; Chi HS; Suh C; Kim H; Kim SR
Eur J Haematol; 2014 Apr; 92(4):313-20. PubMed ID: 24372944
[TBL] [Abstract][Full Text] [Related]
28. Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.
Dremsek P; Schwarz T; Weil B; Malashka A; Laccone F; Neesen J
Genes (Basel); 2021 Dec; 12(12):. PubMed ID: 34946907
[TBL] [Abstract][Full Text] [Related]
29. Optical Genome Mapping: A Promising New Tool to Assess Genomic Complexity in Chronic Lymphocytic Leukemia (CLL).
Puiggros A; Ramos-Campoy S; Kamaso J; de la Rosa M; Salido M; Melero C; Rodríguez-Rivera M; Bougeon S; Collado R; Gimeno E; García-Serra R; Alonso S; Moro-García MA; García-Malo MD; Calvo X; Arenillas L; Ferrer A; Mantere T; Hoischen A; Schoumans J; Espinet B
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884436
[TBL] [Abstract][Full Text] [Related]
30. [Cytogenetic Abnormalities and Outcomes of 117 Patients with Multiple Myeloma Detected by FISH].
Zhai B; Zou DD; Yan JJ; Wang N; Wang LL; Zhu HL; Huang WR; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):127-30. PubMed ID: 26913408
[TBL] [Abstract][Full Text] [Related]
31. Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation.
Greslikova H; Zaoralova R; Filkova H; Nemec P; Oltova A; Kupska R; Rudolecka P; Smetana J; Pour L; Zahradova L; Krejci M; Buchler T; Adam Z; Hajek R; Kuglik P
Neoplasma; 2010; 57(2):111-7. PubMed ID: 20099973
[TBL] [Abstract][Full Text] [Related]
32. Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.
Kriegova E; Fillerova R; Minarik J; Savara J; Manakova J; Petrackova A; Dihel M; Balcarkova J; Krhovska P; Pika T; Gajdos P; Behalek M; Vasinek M; Papajik T
Sci Rep; 2021 Jul; 11(1):14671. PubMed ID: 34282158
[TBL] [Abstract][Full Text] [Related]
33. Clinical Validation and Diagnostic Utility of Optical Genome Mapping in Prenatal Diagnostic Testing.
Sahajpal NS; Mondal AK; Fee T; Hilton B; Layman L; Hastie AR; Chaubey A; DuPont BR; Kolhe R
J Mol Diagn; 2023 Apr; 25(4):234-246. PubMed ID: 36758723
[TBL] [Abstract][Full Text] [Related]
34. A retrospective analysis of cytogenetic and clinical characteristics in patients with multiple myeloma.
He J; Yang L; Meng X; Wei G; Wu W; Han X; Zheng G; Zheng W; Ye X; Shi J; Xie W; Zhang J; Huang H; Lin M; Cai Z
Am J Med Sci; 2013 Feb; 345(2):88-93. PubMed ID: 22986611
[TBL] [Abstract][Full Text] [Related]
35. Clinical Validation and Diagnostic Utility of Optical Genome Mapping for Enhanced Cytogenomic Analysis of Hematological Neoplasms.
Sahajpal NS; Mondal AK; Tvrdik T; Hauenstein J; Shi H; Deeb KK; Saxe D; Hastie AR; Chaubey A; Savage NM; Kota V; Kolhe R
J Mol Diagn; 2022 Dec; 24(12):1279-1291. PubMed ID: 36265723
[TBL] [Abstract][Full Text] [Related]
36. Optical Genome Mapping as a Next-Generation Cytogenomic Tool for Detection of Structural and Copy Number Variations for Prenatal Genomic Analyses.
Sahajpal NS; Barseghyan H; Kolhe R; Hastie A; Chaubey A
Genes (Basel); 2021 Mar; 12(3):. PubMed ID: 33799648
[TBL] [Abstract][Full Text] [Related]
37. High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance.
Yang H; Garcia-Manero G; Sasaki K; Montalban-Bravo G; Tang Z; Wei Y; Kadia T; Chien K; Rush D; Nguyen H; Kalia A; Nimmakayalu M; Bueso-Ramos C; Kantarjian H; Medeiros LJ; Luthra R; Kanagal-Shamanna R
Leukemia; 2022 Sep; 36(9):2306-2316. PubMed ID: 35915143
[TBL] [Abstract][Full Text] [Related]
38. [Role of cytogenetics in the prognosis of patients with multiple myeloma].
Paluszewska M; Dwilewicz-Trojaczek J; Stańczak H; Brycz-Witkowska J; Chmarzyńska-Mróz E; Rokicka M; Torosian T; Wasiutyński A; Jedrzejczak WW
Pol Arch Med Wewn; 2003 Sep; 110(3):973-9. PubMed ID: 14699690
[TBL] [Abstract][Full Text] [Related]
39. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
[TBL] [Abstract][Full Text] [Related]
40. Comparison of Optical Genome Mapping With Conventional Diagnostic Methods for Structural Variant Detection in Hematologic Malignancies.
Shim Y; Koo YK; Shin S; Lee ST; Lee KA; Choi JR
Ann Lab Med; 2024 Jul; 44(4):324-334. PubMed ID: 38433573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
